• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与早发性帕金森病相关的突变α-突触核蛋白加速体外原纤维形成。

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

作者信息

Conway K A, Harper J D, Lansbury P T

机构信息

Center for Neurologic Diseases, Brigham and Women's Hospital and Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Nat Med. 1998 Nov;4(11):1318-20. doi: 10.1038/3311.

DOI:10.1038/3311
PMID:9809558
Abstract

Two mutations in the gene encoding alpha-synuclein have been linked to early-onset Parkinson's disease (PD). alpha-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain. This connection between genetics and pathology suggests that the alpha-synuclein mutations may promote PD pathogenesis by accelerating Lewy body formation. To test this, we studied alpha-synuclein folding and aggregation in vitro, in the absence of other Lewy body-associated molecules. We demonstrate here that both mutant forms of alpha-synuclein (A53T and A30P) are, like wild-type alpha-synuclein (WT), disordered in dilute solution. However, at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T. Thus, mutation-induced acceleration of alpha-synuclein fibril formation may contribute to the early onset of familial PD.

摘要

编码α-突触核蛋白的基因中的两种突变已与早发性帕金森病(PD)相关联。α-突触核蛋白是路易小体的一个组成部分,路易小体是帕金森病大脑中黑质多巴胺能神经元特有的纤维状细胞质内含物。遗传学与病理学之间的这种联系表明,α-突触核蛋白突变可能通过加速路易小体形成来促进帕金森病的发病机制。为了验证这一点,我们在没有其他路易小体相关分子的情况下,在体外研究了α-突触核蛋白的折叠和聚集。我们在此证明,α-突触核蛋白的两种突变形式(A53T和A30P)与野生型α-突触核蛋白(WT)一样,在稀溶液中是无序的。然而,在较高浓度下,会形成路易小体样纤维和离散的球形聚集体;A53T形成得最快。因此,突变诱导的α-突触核蛋白纤维形成加速可能导致家族性帕金森病的早发。

相似文献

1
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.与早发性帕金森病相关的突变α-突触核蛋白加速体外原纤维形成。
Nat Med. 1998 Nov;4(11):1318-20. doi: 10.1038/3311.
2
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.基于大鼠慢病毒的帕金森病模型中的α-突触核蛋白病与选择性多巴胺能神经元丢失
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16.
3
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.帕金森病中α-突触核蛋白mRNA表达的改变。
Mov Disord. 2004 Feb;19(2):162-70. doi: 10.1002/mds.10683.
4
Synphilin-1 is present in Lewy bodies in Parkinson's disease.α-突触核蛋白-1存在于帕金森病的路易小体中。
Ann Neurol. 2000 Apr;47(4):521-3.
5
A Drosophila model of Parkinson's disease.帕金森病的果蝇模型。
Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074.
6
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.由α-突触核蛋白以及与帕金森病相关的两种突变形式在体外形成的原纤维是典型的淀粉样蛋白。
Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r.
7
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.在由酪氨酸羟化酶启动子驱动表达人α-突触核蛋白的转基因小鼠中缺乏黑质病理改变。
Neurobiol Dis. 2001 Jun;8(3):535-9. doi: 10.1006/nbdi.2001.0392.
8
[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].[帕金森病、路易体痴呆、多系统萎缩与α-突触核蛋白]
Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6.
9
Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.在多巴胺存在的情况下,人野生型和突变型α-突触核蛋白对人神经母细胞瘤SH-SY5Y细胞的细胞毒性差异
Biochemistry. 2004 May 11;43(18):5539-50. doi: 10.1021/bi036114f.
10
Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.E46K突变增加了人α-突触核蛋白与磷脂的结合以及组装成细丝的能力。
FEBS Lett. 2004 Oct 22;576(3):363-8. doi: 10.1016/j.febslet.2004.09.038.

引用本文的文献

1
CDK5 Inhibits Synphilin-1 Ubiquitination and Basal Mitophagy: Implications for Parkinson's Disease.细胞周期蛋白依赖性激酶5抑制α-突触核蛋白-1的泛素化及基础线粒体自噬:对帕金森病的影响
Int J Mol Sci. 2025 Aug 20;26(16):8048. doi: 10.3390/ijms26168048.
2
Astrocyte alterations in α-synucleinopathies.α-突触核蛋白病中的星形胶质细胞改变。
Front Cell Neurosci. 2025 Aug 6;19:1650326. doi: 10.3389/fncel.2025.1650326. eCollection 2025.
3
Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson's disease.
神经调节影响T淋巴细胞钙信号传导和α-突触核蛋白清除:对帕金森病的启示。
Front Cell Neurosci. 2025 Jul 18;19:1627305. doi: 10.3389/fncel.2025.1627305. eCollection 2025.
4
Oleuropein Aglycone, an Olive Polyphenol, Influences Alpha-Synuclein Aggregation and Exerts Neuroprotective Effects in Different Parkinson's Disease Models.橄榄苦苷元,一种橄榄多酚,在不同的帕金森病模型中影响α-突触核蛋白聚集并发挥神经保护作用。
Mol Neurobiol. 2025 Jul 24. doi: 10.1007/s12035-025-05208-6.
5
Mechanistic insights and therapeutic innovations in engineered nanomaterial-driven disruption of biofilm dynamics.工程纳米材料驱动生物膜动力学破坏的机制见解与治疗创新
RSC Adv. 2025 Jul 7;15(29):23187-23222. doi: 10.1039/d5ra01711d. eCollection 2025 Jul 4.
6
Parkinson's disease-linked Kir4.2 mutation R28C leads to loss of ion channel function.与帕金森病相关的Kir4.2突变R28C导致离子通道功能丧失。
J Physiol. 2025 Jun;603(12):3499-3518. doi: 10.1113/JP287046. Epub 2025 Jun 25.
7
Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability.硫化氢对α-突触核蛋白聚集及细胞活力的影响。
Sci Rep. 2025 May 4;15(1):15597. doi: 10.1038/s41598-025-99794-z.
8
Loss of intracellular ATP affects axoplasmic viscosity and pathological protein aggregation in mammalian neurons.细胞内三磷酸腺苷(ATP)的缺失会影响哺乳动物神经元中的轴浆粘度和病理性蛋白质聚集。
Sci Adv. 2025 Apr 25;11(17):eadq6077. doi: 10.1126/sciadv.adq6077. Epub 2025 Apr 23.
9
A high-fidelity microfluidic platform reveals retrograde propagation as the main mechanism of α-Synuclein spread in human neurons.一个高保真微流控平台揭示了逆向传播是α-突触核蛋白在人类神经元中传播的主要机制。
NPJ Parkinsons Dis. 2025 Apr 20;11(1):80. doi: 10.1038/s41531-025-00936-x.
10
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.组织巨噬细胞:起源、异质性、生物学功能、疾病及治疗靶点。
Signal Transduct Target Ther. 2025 Mar 7;10(1):93. doi: 10.1038/s41392-025-02124-y.